FDA approves drug for autism irritability

Oct 13, 2006

The U.S. Food and Drug Administration approved Risperdal to treat irritability in autistic children and adolescents.

This is the first time the FDA approved a drug to treat behavior-related problems associated with autism in children, the FDA said in a news release. The drug can be used to treat aggression, deliberate self-injury and temper tantrums, all of which are classified under irritability.

Risperdal is an anti-psychotic drug used to treat adults with schizophrenia, the FDA said. In 2003, it was also approved as a short-term treatment for adults with acute manic episodes or extreme mood swings.

Risperdal is manufactured by Janssen Pharmaceutica N.V. in Beerse, Belgium.

Copyright 2006 by United Press International

Explore further: New treatment approved for rare form of hemophilia

add to favorites email to friend print save as pdf

Related Stories

Russia turns back clocks to permanent Winter Time

5 hours ago

Russia on Sunday is set to turn back its clocks to winter time permanently in a move backed by President Vladimir Putin, reversing a three-year experiment with non-stop summer time that proved highly unpopular.

UN climate talks shuffle to a close in Bonn

5 hours ago

Concern was high at a perceived lack of urgency as UN climate negotiations shuffled towards a close in Bonn on Saturday with just 14 months left to finalise a new, global pact.

Microsoft beefs up security protection in Windows 10

10 hours ago

What Microsoft users in business care deeply about—-a system architecture that supports efforts to get their work done efficiently; a work-centric menu to quickly access projects rather than weather readings ...

US official: Auto safety agency under review

23 hours ago

Transportation officials are reviewing the "safety culture" of the U.S. agency that oversees auto recalls, a senior Obama administration official said Friday. The National Highway Traffic Safety Administration has been criticized ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0